PPT-Naloxone Intranasal Administration

Public Concern Public Expectation All the Other Kids Are Doing It 256403b Opioid Antagonists A law enforcement officer or fire fighter who reasonably believing another person to be undergoing an . O. verdose Prevention Within an Addiction Treatment Program. Neil A. Capretto, D.O., F.A.S.A.M.. Medical . Director. Conflict of Interest . Statement:. Dr. Capretto has no fiduciary or other conflicts of interest to disclose. Alex . Walley. & Maya Doe-. Simkins. on behalf of prescribetoprevent.org. prescribetoprevent.org: . Jenny . Arnold, . PharmD. , . BCPS. Leo . Beletsky. , JD, . MPH. Alice . Bell, . LCSW. Sarah . Catherine Borella Chemistry BA Class of 2016. Senior Chemistry Seminar . University of New Hampshire, Durham, NH, USA. Discussions. How the Government is Mandating Naloxone. Monte-Carlo (MC) Simulation Approach . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . accidental death in America . f. or Ohio . EMS – Version 2.0. NALOXONE ADMINISTRATION:. INTRANASAL ROUTE AND AUTO-INJECTORS. Developed in the 1960s. Opioid antagonist. Emergent overdose treatment in the hospital and prehospital settings. Mark . Peffer. Butler County Sheriff’s Office. Butler County . Naloxone. Manager. David’s Law-. Opioid. Overdose Reversal Act 139. Allows 1. st. Responders to possess and administer . Naloxone. IMPD Southwest District Narcan Pilot Project. Objectives. Overview of the problem . Discuss the basics of opioids. What are opioids?. Illicit and Prescription. Educate on recognition of opioid overdose. Adapted from: . Community . Access . Naloxone Is . there a downside. ?. . Michael . W. Dailey, MD . Albancy. Medical Center. Motor vehicle traffic, poisoning, drug poisoning, and unintentional drug poisoning death rates: United States, 1999--2010. October 24. th. ,. . 2016. Sarah Ruiz, . MSW. , . Naloxone Pilot Program, Massachusetts Department of Public Health. Alexander Walley,. MD, MSc, Medical Director, MDPH Opioid Overdose Prevention Pilot Program. First Responder Naloxone Grant FY18 Webinar Sarah Ruiz, Program Director Dr. Alex Walley, Medical Director Brittni Reilly, Program Coordinator Monday 9/25/2017 Audio:   1-877-838-7060 Agenda Review of Current Statistics / Trends COVID-19 PandemicBACKGROUNDPeople who use drugs and their peers who are often 31rst responders in overdose events need up-to-date and accurate information on the safe administration of naloxone and re Community Placement of Lifesaving Equipment. Naloxone. Overdose antidote. Administered via injection or nasal aerosol. Onset of action 3-15 . mins. Duration of action: 30-45 . mins. Image courtesy of Prescribe to Prevent. NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and . Trainer Name. location AND DATE. Learning objectives. By the end of the presentation, participants will:. Understand requirements of the Community-Based Naloxone Access Program Standing Order. Know what naloxone is and how to store, track and administer it.